Dr. R V Asokan, president of the Indian Medical Association (IMA), criticized Baba Ramdev for claiming he ...More

Dr. R V Asokan, president of the Indian Medical Association (IMA), criticized Baba Ramdev for claiming he could cure COVID-19 and disparaging modern medicine as "stupid and bankrupt." Asokan stated that Ramdev's statements led people to believe him due to his high profile, which was unfortunate. The IMA's comments come ahead of a Supreme Court hearing regarding Ramdev's misleading advertisements. Asokan expressed disappointment with the court's criticism of the IMA and private doctors, saying it demoralized them. ...Less

Supreme Court criticized Uttarakhand Authority for inaction against Patanjali's misleading ads, appreciat ...More

Supreme Court criticized Uttarakhand Authority for inaction against Patanjali's misleading ads, appreciated apologies. Requests proof of newspaper apologies. Ramdev and Balkrishna exempted from court appearance. Bench objects to authority's statements, criminal complaint filed. ...Less

ASM or additional surveillance framework is part of the initiatives taken by the Securities and Exchange ...More

ASM or additional surveillance framework is part of the initiatives taken by the Securities and Exchange Board of India and stock exchanges to enhance market integrity and safeguard the interest of investors. ASM framework is based on objective parameters with price, volume variation, volatility, etc. ...Less

Sequentially, the topline rose just 1.1%, while the bottomline dropped by nearly 15%. The mainstay edible ...More

Sequentially, the topline rose just 1.1%, while the bottomline dropped by nearly 15%. The mainstay edible oils business reported a 15.3% drop in revenue to Rs 5,483 crore, while the FMCG business reported a sharp 64% growth in revenue to Rs 2,499 crore. ...Less

The apex court summoned the duo after Patanjali Ayurved failed to file a reply to a contempt notice issue ...More

The apex court summoned the duo after Patanjali Ayurved failed to file a reply to a contempt notice issued to the company. The case is related to alleged misleading advertisements published by the company for its traditional ayurvedic medicines which claim to cure certain diseases. ...Less

The Food Safety and Standards Authority of India (FSSAI) has directed Patanjali Foods to recall a batch o ...More

The Food Safety and Standards Authority of India (FSSAI) has directed Patanjali Foods to recall a batch of red chilli powder due to non-compliance with safety regulations. The affected batch is labelled AJD2400012. Patanjali Foods, a key player in the FMCG sector, reported a 21% increase in standalone net profit to Rs 308.97 crore for the September quarter. ...Less

Patanjali Foods Q3 Results: Revenue from operations fell 0.2% to Rs 7,911 crore. Sequentially, the toplin ...More

Patanjali Foods Q3 Results: Revenue from operations fell 0.2% to Rs 7,911 crore. Sequentially, the topline rose just 1.1%, while the bottomline dropped by nearly 15%. ...Less

The Delhi High Court on Tuesday directed Patanjali Ayurved to remove the phrase “made with 40 herbs” from ...More

The Delhi High Court on Tuesday directed Patanjali Ayurved to remove the phrase “made with 40 herbs” from its ad allegedly disparaging Dabur Chyawanprash, while allowing the line “why settle for ordinary Chyawanprash” to remain. The court termed this remaining statement as permissible “puffery” and cleared Patanjali to run the modified TV and print advertisements. ...Less

Patanjali Foods shares fell 66.7% on Thursday as the stock turned ex-bonus following a 2:1 bonus issue. T ...More

Patanjali Foods shares fell 66.7% on Thursday as the stock turned ex-bonus following a 2:1 bonus issue. The decline is a technical adjustment, with shareholder value and market capitalization unchanged. Investors now hold three shares instead of one, at a proportionally lower price. The move aims to boost liquidity and broaden retail participation. ...Less